Autoimmune Phenomena After Acute Stroke "ARIMIS"


Phase N/A Results N/A

Summary of Purpose

The damage of the brain parenchyma, as well as the stroke-induced dysfunction of the blood-brain-barrier can make previously hidden CNS antigens "visible", and can thus lead to the development of autoimmune mechanisms. It seems plausible that stroke-associated immunodepression influences the development and the phenotype of these autoreactive immune responses. This study will investigate whether cerebral...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 February 2018.

1 Dec 2009 8 Mar 2010 1 Nov 2011 1 Nov 2011 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Case Control
  • Perspective: Prospective
  • Sampling: Probability Sample